Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar Looking To AquaFlow, ICL To Drive Growth; Firm Cutting Workforce 25%

This article was originally published in The Gray Sheet

Executive Summary

Staar Surgical's revised growth strategy hinges on cutting costs in its mature intraocular lens (IOL) business and sharpening its focus on the high growth, high margin glaucoma and refractive surgery markets, the firm announced Aug. 1.

You may also be interested in...



Staar Surgical Shares Up 62% As Investors Glimpse ICL Clinical Data

Anticipation of strong three-year follow-up data on Staar Surgical's ICL phakic implants helped push the firm's stock up 61.5% in March

Staar Surgical Shares Up 62% As Investors Glimpse ICL Clinical Data

Anticipation of strong three-year follow-up data on Staar Surgical's ICL phakic implants helped push the firm's stock up 61.5% in March

Staar Shipping AquaFlow Glaucoma Drainage Device Following FDA Approval

Staar Surgical is shipping its AquaFlow glaucoma drainage device to 300 physcians already trained in use of the device following FDA approval, announced July 16.

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel